Shanghai Aohua Photoelectricity Endoscope(688212.SH): Net profit for the year 2024 was 21.3218 million yuan, a decrease of 63.15% compared to the previous year.
Australia Hua Endoscopy (688212.SH) released the 2024 annual performance report, reporting that the company achieved operating income of 7...
Shanghai Aohua Photoelectricity Endoscope (688212.SH) released its 2024 annual performance report. During the reporting period, the company achieved operating income of 749 million yuan, an increase of 10.39% year-on-year. The net profit attributable to the owners of the parent company was 21.32 million yuan, a decrease of 63.15% year-on-year. The net loss attributable to the owners of the parent company, excluding non-recurring gains and losses, was 6.99 million yuan. The basic earnings per share were 0.16 yuan per share.
Related Articles

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

Guosen: RWA welcomes the era of strict supervision.

Wondershare Technology Group (300624.SZ) has upgraded its Wondershare Filmora desktop version: free video editing, better AI results!
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

Guosen: RWA welcomes the era of strict supervision.

Wondershare Technology Group (300624.SZ) has upgraded its Wondershare Filmora desktop version: free video editing, better AI results!

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


